Navigation Links
Tiny Sphere Of Nanoparticles Can Fight Cancer

Researchers have found in a preclinical trail, that siRNA packed as a tiny sphere can shrink ovarian cancer.//

Researchers from the University of Texas M. D. Anderson Cancer Centre had reported in the August 15th edition of Clinical Cancer Research, that siRNA that are wrapped up in a tiny sphere infiltrate deeply into ovarian cancer tumour cells, which could thereby oppress the troublesome protein and drastically reducing the size of tumours.

Anil Sood, M.D., associate professor in the Departments of Gynaecologic Oncology and Cancer Biology at M. D. Anderson, and the senior author explained that their experiment that was conducted on a mouse shows the effective delivery system for the short interfering RNA, (siRNA) in attacking the cancer cells.

Short interfering RNA is a great technology we can use to silence genes, shutting down production of harmful proteins, Sood says. 'It works well in the lab, but the question has been how to get it into tumours.' Short pieces of RNA don't make it to a tumour without being injected directly, and injection methods used in the lab are not practical for clinical use.

The research team took siRNA that targets a protein that helps ovarian cancer cells survive and spread and rolled it into a liposome -- a lipid ball so small that its dimensions are measured in nanometers (billionths of a meter).

Getting the siRNA inside tumour cells is important, Sood said, because the targeted protein, focal adhesion kinase (FAK), is inside the cell, rather than on the cell surface where most proteins targeted by cancer drugs are found. 'Targets like FAK, which are difficult to target with a drug, can be attacked with this liposomal siRNA approach, which penetrates deeply into the tumour,' Sood said.

Mice infected with three human ovarian cancer cell lines derived from women with advanced cancer were treated for 3-5 weeks. They received liposomes that contained either the FAK
'"/>




Page: 1 2 3

Related medicine news :

1. Gold Nanoparticles: Agents For Noninvasive Cancer Therapy
2. Alzheimers Can Be Slowed Down By Gold Nanoparticles
3. Gold Nanoparticles Are Good Detectors Biological Toxins
4. Scientists To Study Effect Of Nanoparticles On Liver
5. Nanoparticles and Their Damage to Liver Cells
6. Effect of Nanoparticles on Liver
7. Use of Nanoparticles in Sunscreen under Scrutiny
8. Hybrid Nanoparticles for Multimodal Medical Imaging
9. Nanoparticles Used by Researchers to Attack Brain Tumours
10. Link Between Nanoparticles and Kidney Stones
11. UC Davis Creates New Nanoparticles
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...e for cancer patients in Ontario for radiation has...teady despite the increasing need//. These were th...ency that co-ordinates treatment. Cancer Care Ont...y index launched last year showed a drop in the me...
...eremony of Nepal’s new prime minister Mr. Girija P...n Friday was put off// due to ill health, but his ...e and improving. The 84-year-old, appointed prime ...ening, was scheduled to be administered the oath o...
...re County Hospital (RHCH) in Winchester, which is ... strapped for cash, has been spending ?359,000 car...d treatment. Two elderly patients have been in hos...o not need treatment. Both women have been fit to ...
...llergen is a common trigger of asthma symptoms in ... which feed on scales of human skin, are important...nt in the excrement of the mites attack the respir... asthma. Hence the development of the dust mite va...
Other Medicine News:Health News:Chemotherapy Queues in Ontario Stay Steady 2Health News:Hospitals Facing Huge Losses From Healthy Patients Yet To Discharge 2
(Date:8/14/2008)...stCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS ), a cl...iscovering, developing and commercializing novel d... financial results for the third fiscal,quarter en...attributable to,common stockholders of $15.0 milli...nded June 30, 2008, as compared to a net loss attr...
(Date:8/14/2008)...e 2008 or in early 2009 -, SAN CARLOS, Calif., Au...aq: NUVO ) today announced positive results from ...nstrating that the direct thrombin,inhibitor rapid...rapid,return toward baseline after the infusion en...the potential to address many of the limitations o...
(Date:8/13/2008)...ith Diakron, MORRIS PLAINS, N.J., Aug. 13 /PRNews...oday the signing of an exclusive license agreement...ug candidate discovered and,developed through Phas...terms of the agreement, Diakron has the exclusive ...stribute the compound worldwide., In a simultaneo...
(Date:8/12/2008)...of TB Infection in U.S., SAN FRANCISCO, Aug. 12 /...of tuberculosis (TB) in the U.S., with recurrent o... according to the most recent study on,homelessnes...the Tenderloin,has the highest rates of TB in San ... Anthony,s will offer free tuberculosis screening ...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc. 2National Healthcare for Homeless Day: August 13th, 2008 2Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program 2488 1Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program 2488 2Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program 2488 3Precyse Executive Authors New Book The Legal Health Record 2486 1Precyse Executive Authors New Book The Legal Health Record 2486 2Serta Brings Sweet Dreams and a Special Delivery to Deserving Women 2484 1Serta Brings Sweet Dreams and a Special Delivery to Deserving Women 2484 2Serta Brings Sweet Dreams and a Special Delivery to Deserving Women 2484 3New Software Program Helps Breast Cancer Survivors and Patients Fight Chemofog 2482 1New Software Program Helps Breast Cancer Survivors and Patients Fight Chemofog 2482 2
...ates the Promise of Anacor,s,Boron-Based Chemistry...une 21, 2007 /PRNewswire/ -- Anacor,Pharmaceutical...ced,today that the journal Science will publish re...pany,s lead clinical candidate,kills fungal cells...in required for fungal growth. This unique mechani...
...swire-FirstCall/ -- Keryx,Biopharmaceuticals, Inc....(TM) (sulodexide oral gelcap) have been selected f...essions scheduled to,take place at the upcoming Am...ntific Sessions and exposition at the McCormick Pl... of these abstracts, which highlight the mechanism...
Other Medicine Technology:Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 2Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 4
...x DW4 liquid handling system from Molecular Device... all in one instrument. The system handles a varie...ng96-, 384- and 1536-welland is the first to handl...en optimized to dispense from four different chann...
Embla microplate washers available to handle multiple assays: ELISAs and most cell-based assays. Embla 384 Cell washer has dispense probes that have been optimized to avoid cell disturbance. Both sys
...e miniGene LW is a new plate washing system design...4 channel microplates with flat, V-shaped or U-sha... 16 channel nozzle heads. Simple LCD touch screen ...te stacker is available for the miniGene line wash...
Designed to meet the demands of today's laboratories for RO water.
Medicine Products: